Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neuroblastoma 5Recurrence 2Multiple Myeloma 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Transplant-Related Hematologic Malignancy 1Stomatitis 1Oligodendroglioma 1Neoplasms 1Nasopharyngeal Carcinoma 1Melanoma 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia 1Hodgkin Disease 1Carcinoma, Intraductal, Noninfiltrating 1Brain Neoplasms 1

Interventions

Tamoxifen 6Specimen Handling 6Anastrozole 3exemestane 2Surveys and Questionnaires 2Radiosurgery 2Letrozole 2Genetic Testing 2Biopsy 2poly ICLC 1elacestrant 1Testosterone 1Standard of Care 1Sentinel Lymph Node Biopsy 1Selective Estrogen Receptor Modulators 1Restraint, Physical 1Radiotherapy 1Practice Guidelines as Topic 1Patient Navigation 1Omacor 1Multicenter Studies as Topic 1Methods 1Meditation 1Medicare 1Mastectomy, Segmental 1Mastectomy 1Granulocyte-Macrophage Colony-Stimulating Factor 1Genetic Counseling 1Follow-Up Studies 1FAPI-46 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Carcinoma, Intraductal, Noninfiltrating × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all
NCT04144023 2026-03-05

A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ

Mayo Clinic

Phase 1 Recruiting
43 enrolled
Breast

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡